| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $4.9M | — | +1439.5% |
| SG&A Expense | $2.1M | — | -53.8% |
| Operating Income | -$7.1M | — | -195.5% |
| Interest Expense | $558K | — | +0.0% |
| Net Income | -$6.8M | — | -38.7% |
| EPS (Basic) | -$0.73 | — | +77.3% |
| EPS (Diluted) | -$0.73 | — | +77.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $19.9M | -4.3% | -42.0% |
| Short-term Investments | $5.1M | -49.1% | — |
| Current Assets | $25.3M | -19.7% | — |
| Total Assets | $25.8M | -19.5% | -33.7% |
| Current Liabilities | $11.3M | +2.0% | +838.9% |
| Total Liabilities | $11.3M | +1.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.9M | — | -24.9% |
| Investing Cash Flow | $5.0M | — | +145.7% |
| Financing Cash Flow | -$1.6M | — | -259.3% |
| -75.9% |
| Stockholders' Equity | $14.5M | -30.8% | +279.7% |